Its abundance is inversely correlated with inflammatory bowel disease and type 2 diabetes, but positively correlated with responses to programmed cell-death 1 (PD-1) or programmed cell-death-ligand 1 (PD-L1) checkpoint inhibitors in cancer immunotherapy6,7,13. This evidence concerns the gene PDCD1 and inflammatory bowel disease.